Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production

Chris J Hedegaard, Finn Sellebjerg, Martin Krakauer, Dan Hesse, Klaus Bendtzen, Claus H Nielsen

22 Citationer (Scopus)

Abstract

Treatment with interferon-beta (IFN-beta) increases B-cell activating factor of the TNF family (BAFF) expression in multiple sclerosis (MS), raising the concern that treatment of MS patients with IFN-beta may activate autoimmune B cells and stimulate the production of MS-associated autoantibodies.
OriginalsprogEngelsk
TidsskriftMultiple Sclerosis
Vol/bind17
Udgave nummer5
Sider (fra-til)567-77
Antal sider11
ISSN1352-4585
DOI
StatusUdgivet - 1 maj 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production'. Sammen danner de et unikt fingeraftryk.

Citationsformater